EICHORCondition: Alopecia Areata · Sponsor: Sun Pharmaceutical Industries, Inc.
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Total Skin and Beauty Dermatology Center | Birmingham, Alabama, United States | — |
| Alliance Dermatology & MOHS Center | Phoenix, Arizona, United States | — |
| Center for Dermatology and Plastic Surgery/CCT Research | Scottsdale, Arizona, United States | — |
| Johnson Dermatology | Fort Smith, Arkansas, United States | — |
| Northwest Arkansas Clinical Trials Center, PLLC | Rogers, Arkansas, United States | — |
| Kern Research Inc. | Bakersfield, California, United States | — |
| Hope Clinical Research | Canoga Park, California, United States | — |
| California Dermatology & Clinical Research Institute | Encinitas, California, United States | — |
| University of California, Irvine | Irvine, California, United States | — |
| Dermatology Research Associates | Los Angeles, California, United States | — |
| Quest Dermatology Research | Northridge, California, United States | — |
| Kaiser Permanente Northern California - Oakland | Oakland, California, United States | — |
+ 79 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03898479